HBPCF Stock, Helix Biopharma Corp Information

Helix BioPharma is a biopharmaceutical company specializing in the field of cancer therapy. The Company is developing innovative products for the prevention and treatment of cancer based on its proprietary technologies. Helix s clinical product development initiatives include Topical Interferon Alpha b, for the treatment of conditions caused by the human papilloma virus. Helix is also developing its novel L DOS new drug product candidate for the treatment of lung adenocarcinoma.